MagnaPharm

Magnetic Control of Polymorphism in Pharmaceutical Compounds

MagnaPharm aims at establishing a novel approach to direct polymorphism in pharmaceutical compounds through crystallizing in high magnetic fields, which allows to have a very controlled crystallization in situ and therefore having a transformative effect on almost all pharmaceutical compounds.

  • FFXicon-result-prototypePrototyping phase

MAIN THEMES:

Nanotech & Materials

TOPICS:

High magnetic fieldCrystallizePolymorphism

COORDINATING ORGANISATION:

University of Bristol 

WEBSITE:

www.magnapharm.com/

Stories related to MagnaPharm project

Using magnates to create new medicines

Biotech & Health

By controlling polymorphism in pharmaceutical compounds through the use of magnetic fields, the MagnaPharm project opens up new possibilities in the production of drugs

Discover more stories

Related projects

Graphene Flagship

Developing graphene-based materials for various applications

HYSCORE

Breaking conventional communication networks using quantum entanglement

QuProCS

Building probes to simulate quantum systems

subCULTron

Monitoring the aquatic environmental conditions in the Venice lagoon using robots

Browse all FET projects